GALWAY, Ireland, April 29, 2026 /PRNewswire/ - a global leader in healthcare technology, today announced the successful completion of its first clinical cases using the Stealth AXiS™ Surgical System following recent U.S. Food and Drug Administration (FDA) clearances in February and March. These early cases mark a key milestone as the Stealth AXiS™ system moves from clearance into real-world clinical use, reinforcing Medtronic's leadership in delivering connected, insight-driven technologies [...]
This is an abstract of the document. To keep reading, click here and get access to the original version.